BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30790082)

  • 1. Body composition analysis in patients with myotonic dystrophy types 1 and 2.
    Peric S; Bozovic I; Nisic T; Banovic M; Vujnic M; Svabic T; Pesovic J; Brankovic M; Basta I; Jankovic M; Savic-Pavicevic D; Rakocevic-Stojanovic V
    Neurol Sci; 2019 May; 40(5):1035-1040. PubMed ID: 30790082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI of trunk muscles and motor and respiratory function in patients with myotonic dystrophy type 1.
    Solbakken G; Bjørnarå B; Kirkhus E; Nguyen B; Hansen G; Frich JC; Ørstavik K
    BMC Neurol; 2019 Jun; 19(1):135. PubMed ID: 31216995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies.
    Peric S; Maksimovic R; Banko B; Durdic M; Bjelica B; Bozovic I; Balcik Y; Pesovic J; Savic-Pavicevic D; Rakocevic-Stojanovic V
    J Neurol; 2017 Sep; 264(9):1899-1908. PubMed ID: 28756605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.
    Kornblum C; Lutterbey G; Bogdanow M; Kesper K; Schild H; Schröder R; Wattjes MP
    J Neurol; 2006 Jun; 253(6):753-61. PubMed ID: 16511650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Irisin Is Reduced in Male Patients with Type 1 and Type 2 Myotonic Dystrophies.
    Dozio E; Passeri E; Cardani R; Benedini S; Aresta C; Valaperta R; Corsi Romanelli M; Meola G; Sansone V; Corbetta S
    Front Endocrinol (Lausanne); 2017; 8():320. PubMed ID: 29184538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle involvement in myotonic dystrophy type 2. A comparative muscle ultrasound study.
    Tieleman AA; Vinke A; van Alfen N; van Dijk JP; Pillen S; van Engelen BG
    Neuromuscul Disord; 2012 Jun; 22(6):492-9. PubMed ID: 22414627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy Expenditure, Body Composition, and Skeletal Muscle Oxidative Capacity in Patients with Myotonic Dystrophy Type 1.
    Joosten IBT; Fuchs CJ; Beelen M; Plasqui G; van Loon LJC; Faber CG
    J Neuromuscul Dis; 2023; 10(4):701-712. PubMed ID: 37154183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional body composition and functional impairment in patients with myotonic dystrophy.
    Pruna L; Chatelin J; Pascal-Vigneron V; Kaminsky P
    Muscle Nerve; 2011 Oct; 44(4):503-8. PubMed ID: 21826679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does quantitative EMG differ myotonic dystrophy type 2 and type 1?
    Szmidt-Salkowska E; Gawel M; Lusakowska A; Nojszewska M; Lipowska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
    J Electromyogr Kinesiol; 2014 Oct; 24(5):755-61. PubMed ID: 25052913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes.
    Sansone VA; Brigonzi E; Schoser B; Villani S; Gaeta M; De Ambroggi G; Bandera F; De Ambroggi L; Meola G
    Int J Cardiol; 2013 Sep; 168(2):1147-53. PubMed ID: 23266299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of falls in patients with myotonic dystrophy type 1 and 2: A prospective study.
    Berends J; Tieleman AA; Horlings CGC; Smulders FHP; Voermans NC; van Engelen BGM; Raaphorst J
    Neuromuscul Disord; 2019 Oct; 29(10):758-765. PubMed ID: 31540818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of body composition, metabolism, and pulmonary function in patients with myotonic dystrophy type 1.
    Kikuchi K; Satake M; Furukawa Y; Terui Y
    Medicine (Baltimore); 2022 Sep; 101(36):e30412. PubMed ID: 36086756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1.
    Bachasson D; Moraux A; Ollivier G; Decostre V; Ledoux I; Gidaro T; Servais L; Behin A; Stojkovic T; Hébert LJ; Puymirat J; Eymard B; Bassez G; Hogrel JY
    Neuromuscul Disord; 2016 Jul; 26(7):428-35. PubMed ID: 27234310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition and clinical outcome measures in patients with myotonic dystrophy type 1.
    Sedehizadeh S; Brook JD; Maddison P
    Neuromuscul Disord; 2017 Mar; 27(3):286-289. PubMed ID: 28082208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative muscle MRI as a sensitive marker of early muscle pathology in myotonic dystrophy type 1.
    van der Plas E; Gutmann L; Thedens D; Shields RK; Langbehn K; Guo Z; Sonka M; Nopoulos P
    Muscle Nerve; 2021 Apr; 63(4):553-562. PubMed ID: 33462896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
    Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
    Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.